These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1742450)

  • 1. An adaptive weighted log-rank test with application to cancer prevention and screening trials.
    Self SG
    Biometrics; 1991 Sep; 47(3):975-86. PubMed ID: 1742450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A likelihood ratio test for cancer screening trials.
    Self SG; Etzioni R
    Biometrics; 1995 Mar; 51(1):44-50. PubMed ID: 7766795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximum of the weighted Kaplan-Meier tests with application to cancer prevention and screening trials.
    Shen Y; Cai J
    Biometrics; 2001 Sep; 57(3):837-43. PubMed ID: 11550935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance tests for cancer screening trials.
    Tarone RE; Gart JJ
    Biometrics; 1989 Sep; 45(3):883-90. PubMed ID: 2790126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A generalized log-rank test for interval-censored failure time data via multiple imputation.
    Huang J; Lee C; Yu Q
    Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings.
    Baker SG
    Biometrics; 1998 Dec; 54(4):1569-78. PubMed ID: 9883553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust variance estimation for the case-cohort design.
    Barlow WE
    Biometrics; 1994 Dec; 50(4):1064-72. PubMed ID: 7786988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A parametric model for long-term follow-up data from phase III breast cancer clinical trials.
    Jeong JH; Jung SH; Wieand S
    Stat Med; 2003 Feb; 22(3):339-52. PubMed ID: 12529867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic.
    Chang MN; Shuster JJ
    Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer: epidemiology, risk factors, screening].
    Gairard B; Mathelin C; Schaffer P; Brettes JP
    Rev Prat; 1998 Jan; 48(1):21-7. PubMed ID: 9781206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials.
    Kafadar K; Prorok PC
    Stat Med; 2003 Jan; 22(1):83-111. PubMed ID: 12486753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast complaints during the Dutch nationwide breast cancer screening program: increased risk of referral and of breast cancer].
    van Bon-Martens MJ; Klingenberg H; Dijkstra HA; Peeters PH
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1067-71. PubMed ID: 11414168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation study of the breast cancer risk appraisal for Korean women.
    Lee CY; Ko IS; Kim HS; Lee WH; Chang SB; Min JS; Ham OK; Han JH
    Nurs Health Sci; 2004 Sep; 6(3):201-7. PubMed ID: 15291768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?].
    Chappuis PO
    Rev Med Suisse; 2006 May; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening. Interpreting new data for clinical practice.
    Daly L
    Physician Assist; 1994 Oct; 18(10):47-51, 56, 61-6. PubMed ID: 10138304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population screening for breast cancer: an interim assessment].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for breast cancer mortality among the National Breast Screening Study of Canada participants.
    Busetti MC; Miller AB; To T; Rohan TE
    Cancer Detect Prev; 1996; 20(2):122-9. PubMed ID: 8706037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies.
    Cong XJ; Shen Y; Miller AB
    Stat Med; 2005 Oct; 24(20):3123-38. PubMed ID: 15977269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer stage, social class and the impact of screening.
    Roberts MM; Alexander FE; Elton RA; Rodger A
    Eur J Surg Oncol; 1990 Feb; 16(1):18-21. PubMed ID: 2407559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.